Four-year clinical and echocardiographic outcomes after tricuspid valve replacement using a novel bovine pericardial valve bioprosthesis
Abdullatif Abo Dan, Mahée Côté, Anya Chabane, Paul Borchiellini, Philippe Demers, Michel Pellerin, Pierre-Emmanuel Noly, Denis Bouchard · 2026
Read Four-year clinical and echocardiographic outcomes after tricuspid valve replacement using a novel bovine pericardial valve bioprosthesis by Abdullatif Abo Dan, Mahée Côté, Anya Chabane, Paul Borchiellini, Philippe Demers, Michel Pellerin, Pierre-Emmanuel Noly, Denis Bouchard (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13477042.txt.
Description
Abdullatif Abo Dan and co-authors report four years with a new tissue valve in the heart's tricuspid spot in this 2026 paper. The bovine pericardial valve was designed for another position and used here off-label. Records cover eighty-two patients treated from 2021 to 2025. Most were older and badly symptomatic.
No valve clots appeared, and only two patients needed a repeat procedure for severe leakage. Pressure gradients across the valve stayed low and steady. Early risk was real, though: about one in six patients died within thirty days, and a fifth needed a pacemaker. The authors judge the valve's flow performance sound in a very sick group.
Catalog record
| CREATOR | Abdullatif Abo Dan, Mahée Côté, Anya Chabane, Paul Borchiellini, Philippe Demers, Michel Pellerin, Pierre-Emmanuel Noly, Denis Bouchard |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |